Barclays’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.84M | Buy |
346,659
+170,779
| +97% | +$907K | ﹤0.01% | 2285 |
|
2025
Q1 | $1.56M | Sell |
175,880
-28,171
| -14% | -$250K | ﹤0.01% | 2197 |
|
2024
Q4 | $2.8M | Buy |
204,051
+13,808
| +7% | +$189K | ﹤0.01% | 2001 |
|
2024
Q3 | $5.21M | Buy |
190,243
+109,931
| +137% | +$3.01M | ﹤0.01% | 1501 |
|
2024
Q2 | $1.96M | Sell |
80,312
-64,767
| -45% | -$1.58M | ﹤0.01% | 1721 |
|
2024
Q1 | $3.09M | Sell |
145,079
-54,116
| -27% | -$1.15M | ﹤0.01% | 1644 |
|
2023
Q4 | $3.81M | Buy |
199,195
+56,823
| +40% | +$1.09M | ﹤0.01% | 1697 |
|
2023
Q3 | $2.28M | Buy |
142,372
+13,068
| +10% | +$210K | ﹤0.01% | 1589 |
|
2023
Q2 | $3M | Buy |
129,304
+24,794
| +24% | +$575K | ﹤0.01% | 1495 |
|
2023
Q1 | $2.43M | Sell |
104,510
-36,937
| -26% | -$858K | ﹤0.01% | 1519 |
|
2022
Q4 | $2.05M | Buy |
141,447
+7,203
| +5% | +$105K | ﹤0.01% | 1635 |
|
2022
Q3 | $2.56M | Buy |
134,244
+100,291
| +295% | +$1.91M | ﹤0.01% | 1492 |
|
2022
Q2 | $617K | Sell |
33,953
-37,062
| -52% | -$673K | ﹤0.01% | 2424 |
|
2022
Q1 | $1.79M | Sell |
71,015
-42,698
| -38% | -$1.08M | ﹤0.01% | 1860 |
|
2021
Q4 | $3.14M | Buy |
113,713
+11,289
| +11% | +$312K | ﹤0.01% | 1528 |
|
2021
Q3 | $3.31M | Buy |
102,424
+56,376
| +122% | +$1.82M | ﹤0.01% | 1505 |
|
2021
Q2 | $1.41M | Sell |
46,048
-47,437
| -51% | -$1.45M | ﹤0.01% | 1923 |
|
2021
Q1 | $2.85M | Buy |
93,485
+7,295
| +8% | +$222K | ﹤0.01% | 1607 |
|
2020
Q4 | $1.7M | Sell |
86,190
-68,401
| -44% | -$1.35M | ﹤0.01% | 1671 |
|
2020
Q3 | $2.02M | Buy |
154,591
+83,442
| +117% | +$1.09M | ﹤0.01% | 1494 |
|
2020
Q2 | $807K | Sell |
71,149
-125,948
| -64% | -$1.43M | ﹤0.01% | 2053 |
|
2020
Q1 | $2.82M | Sell |
197,097
-202,150
| -51% | -$2.89M | ﹤0.01% | 1152 |
|
2019
Q4 | $10.9M | Buy |
399,247
+326,653
| +450% | +$8.9M | 0.01% | 814 |
|
2019
Q3 | $2.08M | Sell |
72,594
-45,061
| -38% | -$1.29M | ﹤0.01% | 1725 |
|
2019
Q2 | $3.27M | Buy |
117,655
+69,909
| +146% | +$1.94M | ﹤0.01% | 1400 |
|
2019
Q1 | $1.59M | Buy |
47,746
+17,953
| +60% | +$596K | ﹤0.01% | 1748 |
|
2018
Q4 | $866K | Sell |
29,793
-69,048
| -70% | -$2.01M | ﹤0.01% | 1910 |
|
2018
Q3 | $4.55M | Buy |
98,841
+62,660
| +173% | +$2.88M | ﹤0.01% | 1124 |
|
2018
Q2 | $1.35M | Sell |
36,181
-45,427
| -56% | -$1.7M | ﹤0.01% | 1652 |
|
2018
Q1 | $2.41M | Buy |
81,608
+16,268
| +25% | +$481K | ﹤0.01% | 1264 |
|
2017
Q4 | $2.24M | Sell |
65,340
-24,767
| -27% | -$851K | ﹤0.01% | 1206 |
|
2017
Q3 | $3.26M | Sell |
90,107
-33,776
| -27% | -$1.22M | ﹤0.01% | 979 |
|
2017
Q2 | $3.2M | Buy |
123,883
+22,304
| +22% | +$576K | ﹤0.01% | 977 |
|
2017
Q1 | $1.95M | Sell |
101,579
-13,678
| -12% | -$263K | ﹤0.01% | 1223 |
|
2016
Q4 | $1.92M | Buy |
115,257
+8,273
| +8% | +$138K | ﹤0.01% | 1171 |
|
2016
Q3 | $2.2M | Buy |
106,984
+92,161
| +622% | +$1.9M | ﹤0.01% | 1039 |
|
2016
Q2 | $454K | Buy |
14,823
+6,371
| +75% | +$195K | ﹤0.01% | 1802 |
|
2016
Q1 | $313K | Buy |
8,452
+5,135
| +155% | +$190K | ﹤0.01% | 1909 |
|
2015
Q4 | $143K | Sell |
3,317
-26,945
| -89% | -$1.16M | ﹤0.01% | 2171 |
|
2015
Q3 | $1.12M | Sell |
30,262
-21,048
| -41% | -$780K | ﹤0.01% | 1352 |
|
2015
Q2 | $1.69M | Sell |
51,310
-109,711
| -68% | -$3.62M | ﹤0.01% | 1228 |
|
2015
Q1 | $5.64M | Buy |
161,021
+79,501
| +98% | +$2.78M | 0.01% | 852 |
|
2014
Q4 | $2.77M | Buy |
81,520
+44,141
| +118% | +$1.5M | ﹤0.01% | 1184 |
|
2014
Q3 | $1.42M | Buy |
37,379
+11,403
| +44% | +$433K | ﹤0.01% | 1514 |
|
2014
Q2 | $986K | Buy |
25,976
+510
| +2% | +$19.4K | ﹤0.01% | 1708 |
|
2014
Q1 | $866K | Sell |
25,466
-126,953
| -83% | -$4.32M | ﹤0.01% | 1736 |
|
2013
Q4 | $3.05M | Buy |
152,419
+101,888
| +202% | +$2.04M | ﹤0.01% | 1198 |
|
2013
Q3 | $1.16M | Buy |
50,531
+41,783
| +478% | +$961K | ﹤0.01% | 1614 |
|
2013
Q2 | $235K | Buy |
+8,748
| New | +$235K | ﹤0.01% | 2600 |
|